Primary Radiotherapy of the "intermediate risk" - Prostate Cancer: Comparison between Seeds Brachytherapy and external Radiation therapy (70 or 74 Gy) in 890 Patients

被引:0
|
作者
Goldner, G. [1 ]
Poetter, R. [1 ]
Battermann, J. [2 ]
Schmid, M. P. [1 ]
Sljivic, S. [1 ]
Kirisits, C. [1 ]
van Vulpen, M. [2 ]
机构
[1] Med Univ Wien, Ctr Comprehens Canc, Klin Strahlentherapie & Onkol, Vienna, Austria
[2] Med Univ Utrecht, Dept Radiotherapy & Oncol, Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:59 / 59
页数:1
相关论文
共 50 条
  • [1] Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients
    Goldner, Gregor
    Poetter, Richard
    Battermann, Jan J.
    Kirisits, Christian
    Schmid, Maximilian P.
    Sljivic, Samir
    van Vulpen, Marco
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (02) : 223 - 227
  • [2] Comparison between seeds brachytherapy and external radiation (70 or 74 Gy) in 919 Low-Risk Prostate cancer patients
    Goldner, G.
    Poetter, R.
    Battermann, J.
    Schmid, M. P.
    Sljivic, S.
    Kirisits, C.
    van Vulpen, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 37 - 37
  • [3] Biochemical Control after external Radiotherapy (70/74 Gy) or Brachytherapy Seeds: Comparison in 1809 Patients with Prostate cancer
    Goldner, G.
    Poetter, R.
    Battermann, J.
    Schmid, M. P.
    Kirisits, C.
    Sljivic, S.
    van Vulpen, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (02) : 178 - 178
  • [4] Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients
    Goldner, G.
    Poetter, R.
    Battermann, J. J.
    Schmid, M. P.
    Kirisits, C.
    Sljivic, S.
    van Vulpen, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (04) : 305 - 310
  • [5] Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patientsVergleich von Seeds-Brachytherapie und externer Strahlentherapie (70 bzw. 74 Gy) bei 919 Niedrigrisiko-Prostatakarzinompatienten
    G. Goldner
    R. Pötter
    J.J. Battermann
    M.P. Schmid
    C. Kirisits
    S. Sljivic
    M. van Vulpen
    Strahlentherapie und Onkologie, 2012, 188 (4) : 305 - 310
  • [6] Hormonal Therapy or External Beam Radiation with Brachytherapy and the Risk of Death from Prostate Cancer in Men with Intermediate Risk Prostate Cancer
    Rosenberg, J. E.
    Chen, M.
    Nguyen, P. L.
    Braccioforte, M. H.
    Moran, B. J.
    D'Amico, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S367 - S368
  • [7] Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy
    Markovic, Emily Schlussel
    Buckstein, Michael
    Stone, Nelson N.
    Stock, Richard G.
    BJU INTERNATIONAL, 2018, 121 (05) : 774 - 780
  • [8] Hormonal Therapy or External-Beam Radiation With Brachytherapy and the Risk of Death From Prostate Cancer in Men With Intermediate Risk Prostate Cancer
    Rosenberg, Jonathan E.
    Chen, Ming-Hui
    Nguyen, Paul L.
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    CLINICAL GENITOURINARY CANCER, 2012, 10 (01) : 21 - 25
  • [9] Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy?
    Klein, Eric A.
    Ciezki, Jay
    Kupelian, Patrick A.
    Mahadevan, Arul
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2009, 27 (01) : 67 - 71
  • [10] Treatment Results of Brachytherapy Versus External Beam Radiation Therapy for Intermediate-Risk Prostate Cancer
    Goy, B. W.
    Soper, M. S.
    Chang, T.
    Slezak, J. M.
    Cosmatos, H.
    Tome, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E193 - E193